Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Concurrent Validity and Reliability of the Brazilian Version of the Functioning Assessment Short Test in Patients with Schizophrenia.
Zortéa K, da Silva Magalhães PV, Rosa AR, de Lucena DF, Guimarães LR, Petter Francesconi LP, Pedrini M, Cesar Walz J, Severino Gama C, Kapczinski F, Belmonte-de-Abreu PS. Zortéa K, et al. Among authors: pedrini m. Value Health Reg Issues. 2012 Dec;1(2):244-247. doi: 10.1016/j.vhri.2012.08.001. Epub 2012 Oct 5. Value Health Reg Issues. 2012. PMID: 29702907 Free article.
Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
de Lucena D, Fernandes BS, Berk M, Dodd S, Medeiros DW, Pedrini M, Kunz M, Gomes FA, Giglio LF, Lobato MI, Belmonte-de-Abreu PS, Gama CS. de Lucena D, et al. Among authors: pedrini m. J Clin Psychiatry. 2009 Oct;70(10):1416-23. doi: 10.4088/JCP.08m04935gry. J Clin Psychiatry. 2009. PMID: 19906345 Clinical Trial.
Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity.
Pedrini M, Massuda R, Fries GR, de Bittencourt Pasquali MA, Schnorr CE, Moreira JC, Teixeira AL, Lobato MI, Walz JC, Belmonte-de-Abreu PS, Kauer-Sant'Anna M, Kapczinski F, Gama CS. Pedrini M, et al. J Psychiatr Res. 2012 Jun;46(6):819-24. doi: 10.1016/j.jpsychires.2012.03.019. Epub 2012 Apr 20. J Psychiatr Res. 2012. PMID: 22520512
Serum concentrations of brain-derived neurotrophic factor in patients with gender identity disorder.
Fontanari AM, Andreazza T, Costa ÂB, Salvador J, Koff WJ, Aguiar B, Ferrari P, Massuda R, Pedrini M, Silveira E, Belmonte-de-Abreu PS, Gama CS, Kauer-Sant'Anna M, Kapczinski F, Lobato MI. Fontanari AM, et al. Among authors: pedrini m. J Psychiatr Res. 2013 Oct;47(10):1546-8. doi: 10.1016/j.jpsychires.2013.04.012. Epub 2013 May 20. J Psychiatr Res. 2013. PMID: 23702250
Verbal memory impairment in healthy siblings of patients with schizophrenia.
Massuda R, Bücker J, Czepielewski LS, Narvaez JC, Pedrini M, Santos BT, Teixeira AS, Souza AL, Vasconcelos-Moreno MP, Vianna-Sulzbach M, Goi PD, Belmonte-de-Abreu P, Gama CS. Massuda R, et al. Among authors: pedrini m. Schizophr Res. 2013 Nov;150(2-3):580-2. doi: 10.1016/j.schres.2013.08.019. Epub 2013 Sep 10. Schizophr Res. 2013. PMID: 24035560
Differences in eotaxin serum levels patients with recent onset and in chronic stable schizophrenia: a clue for understanding accelerating aging profile.
Pedrini M, Massuda R, de Lucena D, Macêdo D, Paz AV, Lobato MI, Belmonte-de-Abreu PS, Ceresér KM, Rocha NP, Curra MD, Panizzutti BS, Teixeira AL, Gama CS. Pedrini M, et al. Schizophr Res. 2014 Feb;152(2-3):528-9. doi: 10.1016/j.schres.2013.11.040. Epub 2014 Jan 15. Schizophr Res. 2014. PMID: 24439271 Free article. No abstract available.
BDNF: a biomarker for social vulnerability in individuals diagnosed with gender dysphoria.
Costa AB, Fontanari AM, Andreazza T, Salvador J, Koff WJ, Aguiar B, Ferrari P, Massuda R, Pedrini M, Silveira E, Belmonte-de-Abreu PS, Gama CS, Kauer-Sant'Anna M, Kapczinski F, Lobato MI. Costa AB, et al. Among authors: pedrini m. J Psychiatr Res. 2014 Mar;50:16-7. doi: 10.1016/j.jpsychires.2013.11.009. Epub 2013 Dec 1. J Psychiatr Res. 2014. PMID: 24332481 No abstract available.
Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia.
Gama CS, Canever L, Panizzutti B, Gubert C, Stertz L, Massuda R, Pedrini M, de Lucena DF, Luca RD, Fraga DB, Heylmann AS, Deroza PF, Zugno AI. Gama CS, et al. Among authors: pedrini m. Schizophr Res. 2012 Nov;141(2-3):162-7. doi: 10.1016/j.schres.2012.08.002. Epub 2012 Sep 4. Schizophr Res. 2012. PMID: 22954755
107 results